Literature DB >> 23183952

Prostate cancer: Abiraterone benefit extends to bone-related symptoms.

Sarah Payton.   

Abstract

Entities:  

Year:  2012        PMID： 23183952     DOI： 10.1038/nrurol.2012.232

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  1 in total

1.  Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomised trial.

Authors:  Christopher J Logothetis; Ethan Basch; Arturo Molina; Karim Fizazi; Scott A North; Kim N Chi; Robert J Jones; Oscar B Goodman; Paul N Mainwaring; Cora N Sternberg; Eleni Efstathiou; Dennis D Gagnon; Margaret Rothman; Yanni Hao; Cameron S Liu; Thian S Kheoh; Christopher M Haqq; Howard I Scher; Johann S de Bono
Journal:  Lancet Oncol       Date:  2012-11-09       Impact factor: 41.316
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.